Wednesday, February 8, 2012 Last update: 10:34 PM
The Best of U.S. Company Technology News
Now being accepted at FreshNews.com. See our complete guidelines.
Trade Events
Medtronic, Inc.
News articles for Medtronic, Inc.:
Monday, January 30, 2012
- Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy DevicesMedtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used ... read more
Friday, January 27, 2012
- Medtronic Launches New Minimally Invasive Cardiac Surgery Products Through Exclusive Distribution Agreement with Miami InstrumentsMedtronic, Inc. (NYSE: MDT) today announced that it has entered into an exclusive distribution agreement with Miami Instruments, LLC – a company focused on the design of innovative ... read more
Monday, January 23, 2012
- Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine SurgeryMedtronic, Inc. (NYSE:MDT) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for the Aquamantys® SBS 5.0 Sheathed Bipolar Sealer, a new ... read more
Tuesday, January 17, 2012
- Medtronic Endurant® II AAA Stent Graft System Launches Internationally with CE MarkMedtronic Inc. (NYSE: MDT) today announced the CE (Conformité Européenne) mark and international launch of the Endurant® II AAA Stent Graft System, which meaningfully expands the options ... read more
Wednesday, January 4, 2012
- Medtronic Launches First-of-Its-Kind mySentry(TM) Remote Glucose MonitorToday, Medtronic, Inc. (NYSE:MDT) announced U.S. Food and Drug Administration (FDA) approval and U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a ... read more
Thursday, December 22, 2011
- Medtronic CEO Omar Ishrak to Speak at Goldman Sachs CEO ConferenceMedtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 5, 2012, ... read more
Thursday, November 10, 2011
- Medtronic to Announce Financial Results for Its Second Quarter of the Fiscal Year 2012Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2012 on Tuesday, November 22, 2011. A news release ... read moreActress and Dancer Debbie Allen Teams Up With Medtronic and Urges Americans to "Join the Pace Makers"NEW YORK, Nov. 10, 2011 /PRNewswire/ -- Famed dancer, actress, and director Debbie Allen has teamed up with Medtronic, Inc. (NYSE: MDT) today to kick off "Join the Pace Makers," a national campaign designed to empower people with a condition called bradycardia, also known as a slow heartbeat, to learn ... read more
Wednesday, November 9, 2011
- Retrospective Study Shows New Device Significantly Reduces Blood Loss and Transfusions in Adolescent Scoliosis Corrective SurgeryMedtronic, Inc. (NYSE: MDT) today reported results of an retrospective study available online and in an upcoming print edition of the Journal of Spinal Disorders and Techniques that ... read more
Monday, November 7, 2011
- Medtronic CoreValve® System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve ImplantationMedtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic access. The Medtronic CoreValve ... read more
Friday, November 4, 2011
- Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT) today highlighted scientific sessions of interest on the ... read more
Wednesday, November 2, 2011
- Medtronic Introduces New Procedure for Minimally Invasive Spinal FusionMedtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today a pioneering approach to minimally invasive spinal fusion at the 26th annual meeting of the North ... read moreMedtronic Begins Transcatheter Aortic Valve Trial in JapanMedtronic, Inc. (NYSE: MDT) today announced the first implant in a clinical trial in Japan that will evaluate the safety and effectiveness of the Medtronic CoreValve® System. ... read more
Monday, October 31, 2011
- Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac ArteriesAdvancing the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant® Cobalt Iliac ... read more
Friday, October 28, 2011
- Medtronic Receives IDE Approval to Conduct ASPIRE In-Home Study of First Insulin Pump with Low Glucose Suspend for US MarketIn our continued commitment to develop an artificial pancreas, Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption ... read more
Thursday, October 27, 2011
- FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial FibrillationMedtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic Phased RF Ablation System, the ... read more
Thursday, October 13, 2011
- Medtronic Introduces Two Next-Generation Cardiovascular Devices in JapanMedtronic, Inc. (NYSE: MDT) today announced plans to introduce two of its next-generation cardiovascular devices in Japan, the world’s second largest market for advanced medical technology: the Integrity® ... read more
Tuesday, September 27, 2011
- Medtronic Announces Start of Pivotal Trial for EngagerTM Transcatheter Aortic Valve Implantation SystemMedtronic, Inc. (NYSE: MDT) today announced the start of the Engager™ European Pivotal Trial to pursue CE (Conformité Européenne) Mark for the Engager Transcatheter Aortic Valve Implantation System ... read more
Tuesday, September 20, 2011
- Jury Awards Medtronic $101 Million in Patent Suit against NuVasiveMedtronic, Inc. (NYSE:MDT) announced today that a jury in the United States District Court of the Southern District of California in San Diego, found that NuVasive's CoRoent XL ... read moreMedtronic Responds to United Nations High-Level Meeting on Noncommunicable DiseasesFollowing are statements from Herb Riband, Medtronic vice president of external affairs, and Dr. Jacob Gayle, vice president of Medtronic Foundation and Community Affairs, on the outcomes of ... read more